Ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant Clinical Trials
Conditions / Ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant
Delta Trials catalogs 2 clinical trials for Ultrarapid metabolizer due to cytochrome p450 cyp2d6 variant in its publicly accessible dataset. Within this set, 0 currently recruiting participants and 2 trials have reached completion. This research occurs across 10 participating sites around the world. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations and statuses evolve over time.
Trial Status
2
Total Trials
0
Recruiting
2
Completed
0
Other Active
0
Terminated since 2020
10
Study Locations
Browse by location (10 total)
- Groningen, Netherlands 1 trialAll trials in Groningen, Netherlands
- Amsterdam, Netherlands 1 trialAll trials in Amsterdam, Netherlands
- S'hertogenbosch, Netherlands 1 trialAll trials in S'hertogenbosch, Netherlands
- 's-hertogenbosch, Netherlands 1 trialAll trials in 's-hertogenbosch, Netherlands
- The Hague, Netherlands 1 trialAll trials in The Hague, Netherlands
- Zwolle, Netherlands 1 trialAll trials in Zwolle, Netherlands
- Halsteren, Netherlands 1 trialAll trials in Halsteren, Netherlands
- Heiloo, Netherlands 1 trialAll trials in Heiloo, Netherlands
- Ermelo, Netherlands 1 trialAll trials in Ermelo, Netherlands
- Leeuwarden, Netherlands 1 trialAll trials in Leeuwarden, Netherlands
- Salt Lake City, United States 1 trialAll trials in Salt Lake City, United States